All companies
Visit website
Intelomed
OperatingIntelomed, Inc.
Healthcare · Technology · Founded 2005
Real-time remote health metrics
Post-money valuation ⓘ
$28.2M
As of Jan 2023 · from Intelomed Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$90,388
Across 1 round since 2022
Latest share price
$1.20
Intelomed Preferred Stock 1 offering price
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its source$14K
−$1.3M
2020
$33K
−$1.3M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$14,150
$33,203
Cost of goods sold
$70
$3,752
Gross margin
100%
89%
Net income
-$1,265,112
-$1,266,445
Taxes paid
$0
$0
Balance sheet
Cash
$738,197
$267,374
Accounts receivable
$3,440
$14,760
Total assets
$991,820
$513,556
Short-term debt
$102,511
$108,150
Long-term debt
$4,552,082
$5,334,624
Total liabilities
$4,654,593
$5,442,774
Other
Headcount
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$28.2M
post-money
Intelomed Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $90.4K / $1.1MPost-money $28.2M
Reg CF annual-report compliance
Delinquent
Filed 0 of 4 annual reports (FY2022–FY2025)
Missing: 2022, 2023, 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGARSource: ManualCIK 0001482781Share price $1.20
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.